Kelly Hug, lead cytotechnologist at the Samaritan Hospital laboratory, was the co-author of a paper published in the June 2015 issue of the journal Anticancer Research.
The paper, titled “Expression and Tissue Distribution of MicroRNA-21 in Malignant and Benign Breast Tissues,” included findings related to Hug’s master’s thesis research on breast cancer biomarkers.